Lipoprotein Particle Testing (LPP)

Lipoprotein Particle Profile™ (LPP) testing provides advanced testing for cardiovascular risk, and is more accurate in overall risk assessment than traditional cholesterol blood tests.

Traditional cholesterol and lipid blood testing assess total cholesterol, LDL, HDL and triglycerides. It does not measure particle size, density and quantity, nor does it provide information regarding other major cardiovascular risk markers necessary for targeted treatment.

the LPP test assesses the following:

Detects all major risk markers including Lp(a), remnant lipoprotein (RLP), HDL2b and small (dense) LDL particles.
Measures particle subgroups of VLDL, LDL and HDL.
Does not calculate; rather it directly measures lipoprotein particles numbers and density
Helps in identifying the 50% individuals who have “normal” cholesterol levels that are at risk for heart disease and heart attack.
Measures additional risk markers including C-reactive protein (CRP), homocysteine and insulin.
Measures total cholesterol and triglyceride levels.
Assesses metabolic syndrome traits.

Based on lipid subgroup distribution and other major risk markers noted, a specific therapeutic protocol can be prescribed.